Awards Nomination 20+ Million Readerbase

PMC/PubMed Indexed Articles

Statistical considerations in biosimilar assessment using biosimilarity index

In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation

Google Scholar citation report

Citations : 4890

Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report

Journal of Bioequivalence & Bioavailability peer review process verified at publons

Flyer image

25+ Million Website Visitors

Indexed In

Academic Journals Database
Open J Gate
Genamics JournalSeek
Academic Keys
JournalTOCs
China National Knowledge Infrastructure (CNKI)
CiteFactor
Scimago
Ulrich's Periodicals Directory
Electronic Journals Library
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
MIAR
University Grants Commission
Geneva Foundation for Medical Education and Research
Euro Pub
Google Scholar

View More

Useful Links

Share This Page

Journal Flyer

Journal of Bioequivalence & Bioavailability

Tweets by

Open Access Journals

View More

Research Article - (2017) Volume 9, Issue 4

Policy Practices to Maximise Social Benefit from Biosimilars

Inotai A^1,²^*, Csanádi M^1,³, Vitezic D⁴, Francetic I⁵, Tesar T⁶, Bochenek T⁷, Lorenzovici L^8,⁹, Dylst P¹⁰ and Kaló Z^1,²: ¹Syreon Research Institute, Budapest, Hungary; ²Center for Expert Medicine, Zagreb, Croatia; ³Department of Pharmaceutics and Central Clinical Pharmacy, University of Pécs, Pécs, Hungary; ⁴University of Rijeka School of Medicine and University Hospital Centre Rijeka, Rijeka, Croatia; ⁵Center for Expert Medicine, Zagreb, Croatia; ⁶Department of Organisation and Management in Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia; ⁷Department of Drug Management, Institute of Public Health, Jagiellonian University Medical College, Krakow, Poland; ⁸Syreon Research Romania, Tirgu Mures, Romania; ⁹Faculty of Technical and Human Sciences, Sapientia University, Tirgu Mures, Romania; ¹⁰Biosimilar Medicines Group, Medicines for Europe, Brussels, Belgium

^*Corresponding Author: